​

Celularity (CELU) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CELU Stock Forecast

Celularity (CELU) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 70.45% increase from the last price of $1.76.

- $1 $2 $3 $4 $5 $6 High: $3 Avg: $3 Low: $3 Last Closed Price: $1.76

CELU Stock Rating

Celularity stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 1 Hold (25.00%), 1 Sell (25.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 1 2 Strong Sell Sell Hold Buy Strong Buy

CELU Price Target Upside V Benchmarks

TypeNameUpside
StockCelularity70.45%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.76$1.76$1.76
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24-1---1
Oct, 24-1---1
Sep, 24-1---1
Aug, 24-1---1
Jul, 24-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 23, 2022Asthika GoonewardeneTruist Financial$3.00$1.40114.29%70.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 12, 2022Morgan StanleyEqual-WeightEqual-Weighthold
Apr 26, 2022Truist FinancialHolddowngrade

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-8.04$1.01$-11.02----
Avg Forecast$-11.23$-0.53$-3.50$-5.70$-4.20$-4.60$1.50
High Forecast$-11.23$-0.53$-3.50$-5.70$-4.20$-4.60$1.50
Low Forecast$-11.23$-0.53$-3.50$-5.70$-4.20$-4.60$1.50
Surprise %-28.41%-290.57%214.86%----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$21.34M$17.98M$22.77M----
Avg Forecast$20.45M$15.14M$62.66M$19.63M$65.54M$70.47M$285.66M
High Forecast$20.45M$15.14M$62.66M$19.63M$65.54M$70.47M$285.66M
Low Forecast$20.45M$15.14M$62.66M$19.63M$65.54M$70.47M$285.66M
Surprise %4.32%18.75%-63.66%----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-100.12M$14.19M$-196.29M----
Avg Forecast$-200.00M$-9.49M$-62.35M$-101.53M$-74.81M$-81.94M$26.72M
High Forecast$-200.00M$-9.49M$-62.35M$-101.53M$-74.81M$-81.94M$26.72M
Low Forecast$-200.00M$-9.49M$-62.35M$-101.53M$-74.81M$-81.94M$26.72M
Surprise %-49.94%-249.52%214.85%----

CELU Forecast FAQ

Is Celularity stock a buy?

Celularity stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Celularity is a favorable investment for most analysts.

What is Celularity's price target?

Celularity's price target, set by 4 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 70.45% change from the previous closing price of $1.76.

How does Celularity stock forecast compare to its benchmarks?

Celularity's stock forecast shows a 70.45% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Celularity over the past three months?

  • November 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Celularity’s EPS forecast?

Celularity's average annual EPS forecast for its fiscal year ending in December 2024 is $-5.7, marking a -48.28% decrease from the reported $-11.02 in 2023. Estimates for the following years are $-4.2 in 2025, $-4.6 in 2026, and $1.5 in 2027.

What is Celularity’s revenue forecast?

Celularity's average annual revenue forecast for its fiscal year ending in December 2024 is $19.63M, reflecting a -13.80% decrease from the reported $22.77M in 2023. The forecast for 2025 is $65.54M, followed by $70.47M for 2026, and $285.66M for 2027.

What is Celularity’s net income forecast?

Celularity's net income forecast for the fiscal year ending in December 2024 stands at $-102M, representing a -48.27% decrease from the reported $-196M in 2023. Projections indicate $-74.815M in 2025, $-81.94M in 2026, and $26.72M in 2027.